![Anthony William Tolcher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony William Tolcher
Fondateur chez South Texas Accelerated Research Therapeutics LLC
Profil
Anthony William Tolcher is the founder of South Texas Accelerated Research Therapeutics LLC, which was founded in 2007.
He is currently the President of the company.
In addition to his founding position, he has held former positions as Chairman at American Association of Clinical Oncology, Director at Symphogen A, and Director at Bristol-Myers Squibb FCT bêta, Inc.
Postes actifs de Anthony William Tolcher
Sociétés | Poste | Début |
---|---|---|
South Texas Accelerated Research Therapeutics LLC
![]() South Texas Accelerated Research Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services South Texas Accelerated Research Therapeutics LLC is a global phase research organization focused on accelerating the development of new anticancer drugs with the purpose of improving life and survival of patients with cancer. The company was founded by Anthony W. Tolcher, Amita Patnaik and Kyriakos P. Papadopoulos and is headquartered in San Antonio, TX. | Fondateur | 01/01/2007 |
Anciens postes connus de Anthony William Tolcher
Sociétés | Poste | Fin |
---|---|---|
American Association of Clinical Oncology | Président | - |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
South Texas Accelerated Research Therapeutics LLC
![]() South Texas Accelerated Research Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services South Texas Accelerated Research Therapeutics LLC is a global phase research organization focused on accelerating the development of new anticancer drugs with the purpose of improving life and survival of patients with cancer. The company was founded by Anthony W. Tolcher, Amita Patnaik and Kyriakos P. Papadopoulos and is headquartered in San Antonio, TX. | Commercial Services |
American Association of Clinical Oncology | |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |